A COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE
    1.
    发明申请
    A COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE 审中-公开
    用于生物反应交互的直接建立干细胞模型的组成部分

    公开(公告)号:WO2011159797A3

    公开(公告)日:2012-04-26

    申请号:PCT/US2011040519

    申请日:2011-06-15

    CPC classification number: G01N33/5023 G01N33/5014 G01N33/5041 G01N33/5073

    Abstract: The invention generally features methods for providing engineered pluripotent stem cells that can be used to study biological response and pathways, including differentiation and drug effects. For example, these cells are provided comprising two or more exogenous expression cassettes including a selectable or screenable marker under the control of different condition-responsive regulatory elements, such as differentiation-responsive promoters or regulatory element of a receptor, drug target, drug metabolizing enzyme or signaling pathway gene. Also provided are sets of stem cell lines each comprising a different exogenous expression cassette including a selectable or screenable marker under the control of a different condition-responsive regulatory element.

    Abstract translation: 本发明通常具有用于提供可用于研究生物反应和途径(包括分化和药物作用)的工程多能干细胞的方法。 例如,提供这些细胞,其包含两种或多种外源性表达盒,其包括在不同的条件反应性调节元件的控制下的可选择或可筛选标记,例如受体的分化响应性启动子或调节元件,药物靶标,药物代谢酶 或信号通路基因。 还提供了一组干细胞系,其各自包含不同的外源表达盒,其包含在不同的条件响应性调节元件的控制下的可选择或可筛选标记。

    A COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE
    2.
    发明申请
    A COMPENDIUM OF READY-BUILT STEM CELL MODELS FOR INTERROGATION OF BIOLOGICAL RESPONSE 审中-公开
    用于生物反应中断的准备建立干细胞模型的组成部分

    公开(公告)号:WO2011159797A2

    公开(公告)日:2011-12-22

    申请号:PCT/US2011/040519

    申请日:2011-06-15

    CPC classification number: G01N33/5023 G01N33/5014 G01N33/5041 G01N33/5073

    Abstract: The invention generally features methods for providing engineered pluripotent stem cells that can be used to study biological response and pathways, including differentiation and drug effects. For example, these cells are provided comprising two or more exogenous expression cassettes including a selectable or screenable marker under the control of different condition-responsive regulatory elements, such as differentiation-responsive promoters or regulatory element of a receptor, drug target, drug metabolizing enzyme or signaling pathway gene. Also provided are sets of stem cell lines each comprising a different exogenous expression cassette including a selectable or screenable marker under the control of a different condition-responsive regulatory element.

    Abstract translation: 本发明通常具有用于提供可用于研究生物反应和途径(包括分化和药物作用)的工程多能干细胞的方法。 例如,提供这些细胞包含两种或更多种外源性表达盒,其包括在不同的条件反应性调控元件的控制下的可选择或可筛选标记,例如受体的分化反应性启动子或调节元件,药物靶标,药物代谢酶 或信号通路基因。 还提供了一组干细胞系,其各自包含不同的外源表达盒,其包含在不同的条件响应性调节元件的控制下的可选择或可筛选标记。

Patent Agency Ranking